Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coarsucam vs Coartem for Repeated Malaria in Children
NCT00699920Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of artesunate + amodiaquine in Plasmodium falciparum malaria (2 arms), sponsored by Sanofi. Primary endpoint: PCR adjusted adequate clinical and parasitological response at Day 28. Started Jun 2008; status: completed.
02
Drugs
artesunate + amodiaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00699920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699920.